Company: LGNZZ
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0000886163-25-000025
Chunk: 68

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 68
---
-PEO NEOs for each applicable fiscal year and the Option Exercises and Stock Vested table for the value realized by each of them upon the exercise of stock options and/or vesting of stock awards during the applicable fiscal year.

For 2024, c ompensation actually paid to our NEOs represents the “Total” compensation reported in the Summary Compensation Table, as adjusted as follows:

53

54

|               |     |      |      |     | Adjustments(1)                                                                                                 |            |     |                                                                                                     |           |     |                                                                                          |           |     |                                                                                                                         |           |     |                                                                                 |          |     |                                       |            |
|               |     | Year |      |     | Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for ($) |            |     | Change in Fair Value  from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards ($) |           |     | Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year ($) |           |     | Change in  Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year ($) |           |     | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year ($) |          |     | Total - Inclusion of Equity Value ($) |            |
| Todd C. Davis |     | 2024 |      |     |                                                                                                                | 13,278,883 |     |                                                                                                     | 5,249,067 |     |                                                                                          | 1,326,953 |     |                                                                                                                         |   512,268 |     |                                                                                 |        — |     |                                       | 20,367,171 |
| Non-PEO NEOs  |     |      | 2024 |     |                                                                                                                |  1,968,111 |     |                                                                                                     | 1,528,763 |     |                                                                                          | 1,113,519 |     |                                                                                                                         | 1,232,247 |     |                                                                                 | -322,301 |     |                                       |  5,520,339 |

(1) Fair value or change in fair value, as applicable, of equity awards in the “Compensation Actually Paid” columns was determined by reference to (i) for solely service-vesting RSU awards, the closing price per share on the applicable year